Xeris Biopharma Holdings Inc (XERS)

Apr 14, 2026

Record Profitability, 2026 Growth Outlook and Recorlev Patent Suit Might Change The Case For Investing In Xeris Biopharma Holdings (XERS) - Sahm

Apr 14, 2026

Apr 13, 2026

XERS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 13, 2026

Apr 13, 2026

Does Record Q4 Results, Robust 2026 Guidance and Recorlev Patent Suit Change The Bull Case For Xeris (XERS)? - Yahoo Finance

Apr 13, 2026

Apr 12, 2026

Barclays Initiates Coverage on Xeris Biopharma Holdings (XERS) w - GuruFocus

Apr 12, 2026

Apr 10, 2026

XERS.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 10, 2026

Apr 09, 2026

Earnings Recap: Why is Xeris Biopharma Holdings Inc stock going upWeekly Stock Summary & Verified Short-Term Trading Plans - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Q1 2025 Xeris Biopharma Holdings Inc Earnings Call Transcript - GuruFocus

Apr 08, 2026

Apr 08, 2026

XERS Should I Buy - Intellectia AI

Apr 08, 2026

Apr 08, 2026

XERS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 08, 2026

Apr 08, 2026

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Q4 2025 Earnings Beat - Sahm

Apr 08, 2026

Apr 07, 2026

Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue? - MSN

Apr 07, 2026

Apr 06, 2026

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)April 3, 2026 - BioSpace

Apr 06, 2026

Apr 05, 2026

Oppenheimer Maintains Xeris Biopharma Holdings (XERS) Outperform Recommendation - MSN

Apr 05, 2026

Apr 04, 2026

XERS Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Xeris Biopharma (NASDAQ:XERS) Insider Sells $99,835.33 in Stock - MarketBeat

Apr 03, 2026

Apr 03, 2026

Beth Hecht Sells 16,667 Shares of Xeris Biopharma Holdings Inc (XERS) - GuruFocus

Apr 03, 2026

Apr 03, 2026

Xeris Biopharma Approves Inducement Grants for 50,000 Shares to Two New Employees - geneonline.com

Apr 03, 2026

Apr 03, 2026

Xeris Biopharma (XERS) officer sells 16,667 shares under 10b5-1 plan - Stock Titan

Apr 03, 2026

Apr 02, 2026

James Aloysius Brady Sells 10,834 Shares of Xeris Biopharma (NASDAQ:XERS) Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Tudor Investment Corp ET AL Decreases Stake in Xeris Biopharma Holdings, Inc. $XERS - marketbeat.com

Apr 02, 2026

Apr 01, 2026

Insider Sell: James Brady Sells Shares of Xeris Biopharma Holdin - GuruFocus

Apr 01, 2026

Apr 01, 2026

Brady sells Xeris Biopharma (XERS) shares worth $60,035 By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Brady sells Xeris Biopharma (XERS) shares worth $60,035 - Investing.com

Apr 01, 2026

Apr 01, 2026

Xeris Biopharma (XERS) director sells 10,834 shares in Rule 10b5-1 trades - Stock Titan

Apr 01, 2026

Mar 31, 2026

XERS Stock Price, Quote & Chart | XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) - ChartMill

Mar 31, 2026

Mar 30, 2026

[144] Xeris Biopharma Holdings, Inc. SEC Filing - Stock Titan

Mar 30, 2026

Mar 30, 2026

Aug Macro: Will Xeris Biopharma Holdings Inc stock recover after earningsEntry Point & AI Enhanced Trading Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 30, 2026

Mar 28, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Mar 28, 2026

Mar 27, 2026

Vanguard (XERS) disaggregates holdings after Jan 12, 2026 realignment; reports 0 shares - Stock Titan

Mar 27, 2026

Mar 26, 2026

Revenue per share of Xeris Biopharma Holdings, Inc. – LSE:0A8E - TradingView

Mar 26, 2026

Mar 26, 2026

Xeris Biopharma shares rise nearly 3% after Q4 earnings beat and strong 2026 outlook - MSN

Mar 26, 2026

Mar 26, 2026

Xeris Biopharma (NASDAQ:XERS) Shares Up 5.4%What's Next? - MarketBeat

Mar 26, 2026

Mar 21, 2026

Market Review: Can Xeris Biopharma Holdings Inc keep up with sector leaders - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Xeris Biopharma stock faces analyst scrutiny amid pipeline delays and biotech volatility - AD HOC NEWS

Mar 21, 2026

Mar 19, 2026

Barclays reiterates Xeris Pharmaceuticals stock rating on sales outlook By Investing.com - Investing.com Canada

Mar 19, 2026

Mar 17, 2026

350,168 Shares in Xeris Biopharma Holdings, Inc. $XERS Purchased by Granahan Investment Management LLC - MarketBeat

Mar 17, 2026

Mar 16, 2026

Xeris Biopharma (NASDAQ: XERS) officer boosts stake via option exercise - Stock Titan

Mar 16, 2026

Mar 16, 2026

Divisadero Street Capital Management LP Takes $3.31 Million Position in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat

Mar 16, 2026

Mar 13, 2026

Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Rosalind Advisors Inc. - MarketBeat

Mar 13, 2026

Mar 11, 2026

Xeris Biopharma Holdings (XERS) Price Target Increased by 27.78% to 11.73 - MSN

Mar 11, 2026

Mar 11, 2026

Transcript : Xeris Biopharma Holdings, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11 - marketscreener.com

Mar 11, 2026

Mar 11, 2026

XERS: RECORLEV's rapid growth and pipeline advances drive strong financial and strategic momentum - TradingView

Mar 11, 2026

Mar 09, 2026

Xeris Biopharma (XERS) Q4 2025 Earnings Transcript - AOL.com

Mar 09, 2026

Mar 09, 2026

Assessing Xeris Biopharma Holdings (XERS) Valuation After Profitability Milestone And 2026 Revenue Guidance - simplywall.st

Mar 09, 2026

Mar 07, 2026

XERS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 07, 2026

Mar 07, 2026

Xeris Pharmaceuticals Q2 2025 Earnings Preview - MSN

Mar 07, 2026